Project Grant R44DK146647
Award Date 8/25/26
Completion Date 7/31/28
Dollars Obligated $923K
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Irvine, CA 92618, USA
Similar Awards
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded $275,275 to Integrated Medical Sensors Inc. on September 17, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to develop a miniaturized and flexible continuous glucose monitoring platform. Integrated Medical Sensors will optimize the design of its electrochemical analyte sensing platform by expanding the use of flexible electronics to create a first-in-class band-aid...
- The National Science Foundation awarded Integrated Medical Sensors Inc. a $256,000 Project Grant under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a novel multi-analyte microsensor platform for continuous wireless monitoring applications. The grant aims to create a unique monolithic semiconductor platform capable of wirelessly monitoring multiple biochemical and physiological markers simultaneously in a sub-cubic millimeter footprint. This miniature,...
- The National Science Foundation (NSF) Division of Chemical, Bioengineering, Environmental, and Transport Systems awarded a $450,000 Project Grant to the Texas A&M Engineering Experiment Station (Tees) to develop an injectable, grain-of-rice size glucose biosensor for continuous blood sugar monitoring. The key products or services to be provided under this 3-year grant include: Developing an injectable glucose biosensor comprised of a self-cleaning membrane and a near-infrared fluorescence...
- This Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program totaling $511,798 was awarded to Kilele Health Inc. on June 15, 2022 to develop continuous diagnostic monitoring platforms beyond glucose sensing. Unlike existing enzymatic glucose sensors, the company will utilize electrochemical aptamer sensors that can rapidly measure other molecules in the body with high specificity and sensitivity. The aim is to address limitations that have...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Johns Hopkins University $1.638 million on September 11, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct research using continuous glucose monitoring systems and machine learning methods to identify glucose pattern clusters and high-risk subgroups in persons with and without diabetes. The project, titled "Glucose Patterns and Clinical Outcomes in the...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Brigham & Women's Hospital $891,382 on May 15, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a multisite evaluation of continuous glucose monitoring (CGM) effectiveness in older adults with type 2 diabetes. The recipient will assess how CGM-derived metrics influence clinician behavior and therapeutic decision-making, compare clinical outcomes and care...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded Scripps Health $331,277 on September 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to fund research integrating continuous glucose monitoring (CGM) in diabetes self-management education and support to improve glycemic control in Latino adults with type 2 diabetes. The research, titled "Integrating Continuous Glucose Monitoring in Diabetes Self-Management...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Research Foundation For The State University Of New York $799,752 on July 1, 2026, to conduct a randomized controlled trial comparing the efficacy of continuous glucose monitoring relative to traditional finger-stick self-monitoring of blood glucose in non-insulin-treated adults with poorly controlled type 2 diabetes. The study randomizes approximately 240 participants (≥8% of whom identify as African American) in a...
- The National Science Foundation awarded Micromedics Inc. $304,926 on July 1, 2026, under the NSF Technology, Innovation, and Partnerships program (CFDA 47.084) to design and develop the mPancreas, a wearable biomimetically designed microfluidic bioartificial pancreas device. The research focuses on creating a compact implanted device that recreates the small-scale biological environment required for insulin-producing cells to survive and function outside the body. The device uses thin...
- The National Institute of Diabetes and Digestive and Kidney Diseases awarded the University of Houston $784,276 on July 1, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to evaluate the impact of continuous glucose monitors (CGMs) on prediabetes management in Federally Qualified Health Center (FQHC) populations through a five-year project concluding June 30, 2031. The research, titled SMART Prediabetes (Supporting Monitoring and Remote Tracking...